Affymetrix Estimates $15 Million Shortfall for Fourth Quarter
January 5, 2006
Santa Clara, CA 1/5/05—Affymetrix has announced that it expects fourth quarter 2005 revenues of $115 million, $15 million below the company’s previous guidance of $120 million. Affymetrix estimates 2005 total revenues of $365 million, for annual growth of 5.5%, and 2005 product and product-related revenues of $350 million, for growth of 5.7%. In 2006, Affymetrix [...]
QIAGEN and Eppendorf Form Alliance for Development and Marketing of Life Science Solutions
January 5, 2006
Venlo , The Netherlands and Hamburg , Germany – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt , Prime Standard: QIA) and Eppendorf AG today announced that they have formed a strategic alliance that includes co-development and co-marketing of complementary and optimized products. The alliance is intended to link two of the strongest brands and product lines in [...]
GE Healthcare Completes IDX Acquisition
January 4, 2006
BARRINGTON, Ill., — GE Healthcare, a unit of General Electric Company (NYSE: GE), announced the completion of the company’s acquisition of IDX Systems Corporation (NASDAQ: IDXC), a leading healthcare information technology (IT) provider. GE expects the acquisition to accelerate efforts to seamlessly connect clinicians from physicians’ offices to hospitals with comprehensive, enterprise-wide electronic health record [...]
Applied Biosystems Acquires Ambion
December 27, 2005
Foster City, CA and Austin, TX —Applied Biosystems has signed a definitive agreement to acquire Ambion’s Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion’s Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion’s 2005 revenues are forecasted to increase 22% to more [...]
Applied Biosystems Acquires RNA Reagent Supplier Ambion
December 27, 2005
Foster City, CA and Austin, TX —Applied Biosystems has signed a definitive agreement to acquire Ambion’s Research Products Division, a supplier of RNA-based reagents, for $273 million in cash. Ambion’s Research Products Division sells sample preparation, RNAi, micro RNA, and gene expression and array products. Ambion’s 2005 revenues are forecasted to increase 22% to more [...]
New Developments in Portable XRF Technology
December 27, 2005
Thermo Electron Corporation’s NITON Analyzers announces the introduction of the first hand-held X-Ray Fluorescence (XRF) analyzer equipped with a helium purging mechanism for direct analysis of so-called “light elements”. Thermo’s line of NITON portable XRF analyzers has been recognized worldwide for their ability to provide immediate chemical analysis of alloys, electronic materials, coatings, plastics and [...]
December 20, 2005
BREMEN, GOETTINGEN and Tuebingen, Germany - - Bruker Daltonik GmbH, the University of Goettingen and German biotech company PANATecs GmbH today announced a new development collaboration in protein biomarker discovery and molecular diagnostics research based on mass spectrometry. PANATecs will apply Bruker Daltonics’ CLINPROT™ tools for biomarker discovery, profiling and identification in the field of [...]
Invitrogen Acquires Cell Expansion Technology and Provides Forecast
December 15, 2005
Seattle, WA and Carlsbad, CA- Invitrogen has agreed to acquire Xcyte Therapies’ cell expansion technology, including intellectual property, clinical data, raw materials and equipment, for $5 million in cash. In addition, Xcyte will also be entitled to a percentage of sublicensing revenue related to the intellectual property for therapeutic applications. “To Invitrogen, this transaction represents [...]
MKS Instruments Aquires Software Firm Umetrics AB
December 15, 2005
Wilmington, MA –Process Monitoring and control technologies provider MKS Instruments has agreed to acquire Umetrics AB, a maker of multivariate data analysis and modeling software for semiconductor, pharmaceutical, petrochemical and manufacturing processes. Terms of the transaction were not announced. “I am pleased that our partnership with Umetrics has expanded beyond our exclusive license agreement, and [...]
Cellectricon launches Pioneering Systems for Adherent Cell Electroporation
December 14, 2005
Gothenburg, Sweden -- Cellectricon today announced the launch of the new CellaxessTM CX1 and CX3 Systems for adherent cell electroporation based on Cellectricon’s patented (U.S. Patent #6,521,430) capillary electroporation technology. The technology provides new possibilities for hard-to-transfect cells. Developed for life scientists, Cellaxess offers novel transfection capabilities based on patented and revolutionary capillary electroporation technology. [...]